Key result
Subsegmental pulmonary embolism accounted for 3.8% of all pulmonary embolisms and was associated with similar 3-month rates of mortality, VTE recurrence, and major bleeding compared to more proximal or no pulmonary embolism.
Why the study?
Subsegmental pulmonary embolism incidence has increased with imaging improvements, but treatment clinical equipoise persists, and existing studies have significant heterogeneity and lack adequately matched comparator groups.
Does the presence of subsegmental pulmonary embolism compared to other PE types or no PE affect 3-month mortality, VTE recurrence, and major bleeding in adults undergoing CTPA?
Observational (n=395)
Yes
Does the presence of subsegmental pulmonary embolism compared to other PE types or no PE affect 3-month mortality, VTE recurrence, and major bleeding in adults undergoing CTPA?
Subsegmental pulmonary embolism accounts for 3.8% of all PEs and has similar 3-month mortality, VTE recurrence, and major bleeding compared to other PE types or no PE, often presenting with alternative radiological findings that may explain symptoms.
Answers are grounded in this paper and cite their sources.
SSPE outcomes similar across comparator groups; leaves open optimal anticoagulation strategy pending randomized trials.
BACKGROUND: The incidence of subsegmental pulmonary embolism (SSPE) has increased with improvements in imaging technology. There is clinical equipoise for SSPE treatment, with conflicting evidence of improved mortality or reduced venous thromboembolism recurrence with anticoagulation. SSPE studies have significant heterogeneity and often lack adequately matched disease comparator groups. OBJECTIVES: To determine the prevalence, management, and outcomes of SSPE and compare them to patients with main, lobar, segmental, and no pulmonary embolism (PE). PATIENTS/METHODS: All adult patients undergoing CT pulmonary angiography (CTPA) between 2013 and 2019, at 3 UK hospitals were included in the study. CTPA reports were text mined for language relating to PE, and then further manually screened for the presence and anatomical location of PE. Patient groups were propensity matched by age, sex, and year of CTPA prior to analysis. 3-month outcomes of major bleeding, VTE recurrence, and death were recorded. RESULTS: 79 (3.8%) SSPEs were identified from 2,055 diagnoses of PE, and 14,300 CTPA reports. 44 (56%) of SSPEs were single artery emboli, 25 (32%) were multiple unilateral emboli, and 10 (13%) were multiple bilateral emboli. Mortality, VTE recurrence and major bleeding were similar at 3 months across all groups. 87.3% of SSPE imaging reports had an additional radiological diagnosis, with pleural effusion (30%), consolidation (19%), and cardiomegaly (19%) being the most common. CONCLUSION: The prevalence of SSPE was 3.8% of all PEs and there were a substantial number of additional radiological findings in the SSPE group that may have accounted for their symptoms.
No takes yet. Share an insight, caveat, or question.
Armitage et al. (2022) conducted an observational in Subsegmental pulmonary embolism (n=395). Subsegmental pulmonary embolism vs. More proximal pulmonary embolism or no pulmonary embolism was evaluated on 3-month mortality, VTE recurrence, and major bleeding. Subsegmental pulmonary embolism accounted for 3.8% of all pulmonary embolisms and was associated with similar 3-month rates of mortality, VTE recurrence, and major bleeding compared to more proximal or no pulmonary embolism.
Synapse has enriched 10 related papers. Consider them for comparative context: